Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSNI
4426
CALL
DELISTED
HSN, Inc.
HSNI
| $1.05M | ﹤0.01% |
26,100
-5,700
| -18% | -$225K |
|
4427
Modine Manufacturing
MOD
$11.1B
| $1.05M | ﹤0.01% |
52,058
+4,041
| +8% | +$86.8K |
|
4428
CALL
Unilever
UL
$134B
| $1.05M | ﹤0.01% |
16,889
-7,111
| -30% | -$451K |
|
4429
Tootsie Roll Industries
TR
$3.08B
| $1.05M | ﹤0.01% |
37,609
+28,593
| +317% | +$800K |
|
4430
PUT
Synopsys
SNPS
$80.7B
| $1.05M | ﹤0.01% |
12,300
+9,300
| +310% | +$805K |
|
4431
S&T Bancorp
STBA
$1.8B
| $1.05M | ﹤0.01% |
26,315
-17,440
| -40% | -$706K |
|
4432
CALL
Primerica
PRI
$9.65B
| $1.05M | ﹤0.01% |
10,300
-7,100
| -41% | -$677K |
|
4433
CALL
Qualys
QLYS
$6.44B
| $1.04M | ﹤0.01% |
17,600
+11,800
| +203% | +$663K |
|
|
IMGN
4434
DELISTED
Immunogen Inc
IMGN
| $1.04M | ﹤0.01% |
162,949
-36,890
| -18% | -$228K |
|
|
OCLR
4435
CALL
DELISTED
Oclaro Inc.
OCLR
| $1.04M | ﹤0.01% |
155,000
+37,800
| +32% | +$279K |
|
4436
BJ's Restaurants
BJRI
$1.45B
| $1.04M | ﹤0.01% |
28,678
-593,104
| -95% | -$19.8M |
|
4437
CALL
ProShares UltraShort Gold
GLL
$104M
| $1.04M | ﹤0.01% |
3,775
+850
| +29% | +$245K |
|
|
INC
4438
DELISTED
ISHARES U S ETF TRFXD INCOME BALANCED RISK ETF (DE)
INC
| $1.04M | ﹤0.01% |
10,426
+5,534
| +113% | +$554K |
|
4439
PUT
Core Laboratories
CLB
$571M
| $1.04M | ﹤0.01% |
9,500
-12,500
| -57% | -$1.25M |
|
4440
VanEck Pharmaceutical ETF
PPH
$985M
| $1.04M | ﹤0.01% |
17,512
-998
| -5% | -$57.2K |
|
4441
Forrester Research
FORR
$217M
| $1.04M | ﹤0.01% |
23,501
-727
| -3% | -$32.6K |
|
|
OA
4442
PUT
DELISTED
Orbital ATK, Inc.
OA
| $1.04M | ﹤0.01% |
7,900
-2,700
| -25% | -$358K |
|
|
BEAT
4443
CALL
DELISTED
BioTelemetry, Inc.
BEAT
| $1.04M | ﹤0.01% |
34,700
-1,600
| -4% | -$46.3K |
|
4444
CALL
Carter's
CRI
$1.42B
| $1.03M | ﹤0.01% |
8,800
+2,900
| +49% | +$300K |
|
|
COBZ
4445
DELISTED
CoBiz Financial,Inc
COBZ
| $1.03M | ﹤0.01% |
51,716
+1,125
| +2% | +$22.8K |
|
|
KND
4446
DELISTED
Kindred Healthcare
KND
| $1.03M | ﹤0.01% |
106,509
-643,361
| -86% | -$4.79M |
|
|
POT
4447
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.03M | ﹤0.01% |
50,047
-113,936
| -69% | -$2.21M |
|
4448
CALL
Teucrium Corn Fund
CORN
$171M
| $1.03M | ﹤0.01% |
61,400
+14,100
| +30% | +$241K |
|
4449
Travel + Leisure Co
TNL
$4.63B
| $1.03M | ﹤0.01% |
19,669
-51,005
| -72% | -$2.53M |
|
|
CBM
4450
DELISTED
Cambrex Corporation
CBM
| $1.03M | ﹤0.01% |
21,435
-59,569
| -74% | -$2.95M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.